Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenbai Granules for Preventing Recurrent Colorectal Adenomas
NCT03616444Phase 3Completed
- Sponsor
- Jiangsu Famous Medical Technology
- Start
- Dec 2018
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Shenbai Granules in Colorectal Adenoma (CRA) (2 arms), sponsored by Jiangsu Famous Medical Technology. Primary endpoint: Adenoma detection rate at 2 years. Started Dec 2018; status: completed.
02
Drugs
Shenbai Granules
03
Conditions
Colorectal Adenoma (CRA)
Beyond the preview
Go deeper on NCT03616444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03616444.